CAR-T treatment of pediatric AML: a long and winding road

被引:8
|
作者
De Moerloose, Barbara [1 ]
机构
[1] Ghent Univ Hosp, Ghent, Belgium
关键词
D O I
10.1182/blood.2020009406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this issue of Blood, Willier et al explored the differences in immunotarget expression in pediatric (ped) acute myeloid leukemia (AML) compared with adult AML. They identified CD33 and CLEC12A (CLL1) as the best combination for immunotherapy in ped AML. Their findings underscore the need to delineate immunotarget expression levels prior to (pre-)clinical application of chimeric antigen receptor (CAR)-T-cell treatment.(1)
引用
收藏
页码:1004 / 1006
页数:4
相关论文
共 50 条
  • [21] CAR-T Cells for the Treatment of Lung Cancer
    Chocarro, Luisa
    Arasanz, Hugo
    Fernandez-Rubio, Leticia
    Blanco, Ester
    Echaide, Miriam
    Bocanegra, Ana
    Teijeira, Lucia
    Garnica, Maider
    Morilla, Idoia
    Martinez-Aguillo, Maite
    Pineiro-Hermida, Sergio
    Ramos, Pablo
    Lasarte, Juan Jose
    Vera, Ruth
    Kochan, Grazyna
    Escors, David
    LIFE-BASEL, 2022, 12 (04):
  • [22] The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
    Singh, Kanal
    Rocco, Joseph M.
    Nussenblatt, Veronique
    SEMINARS IN HEMATOLOGY, 2024, 61 (05) : 321 - 332
  • [23] CAR-T cells for pediatric brain tumors: Present and future
    Leruste, Amaury
    Beccaria, Kevin
    Doz, Francois
    BULLETIN DU CANCER, 2021, 108 (10) : S109 - S116
  • [24] Mixed Findings in Pediatric Neuroblastoma CAR-T Therapy Trial
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (02): : 121 - 121
  • [25] TIM-3 TARGETING CAR-T CELLS, AS A POTENTIAL IMMUNOTHERAPY FOR AML
    Lee, S.
    Ye, Z. Y.
    Huang, H.
    Soh, M. K.
    Wang, Cheng-I
    HUMAN GENE THERAPY, 2018, 29 (11) : A12 - A12
  • [26] CAR-T Cells
    Maloney, David G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S100 - S101
  • [27] Long-term Survivors and Failures of CAR-T Therapy for Lymphoma: Is there a Role for Allogeneic Transplantation After the CAR-T Crash?
    Spinner, Michael A.
    Komanduri, Krishna, V
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (12): : 725 - 726
  • [28] The long and winding road
    Stauffer, M
    BEHAVIORAL HEALTHCARE TOMORROW, 1996, 5 (03): : 17 - 18
  • [29] SPINAL CORD INFARCT AFTER CAR-T TREATMENT
    Shah, Rusha
    Venur, Vyshak
    McGranahan, Tresa
    NEURO-ONCOLOGY, 2021, 23 : 149 - 149
  • [30] The long and winding road
    Lupia, Tommaso
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (08) : 841 - 841